• Home
  • MedDevices AI
  • Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?

Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?

Key Highlights:

  • Levita Magnetics’ MARS® platform used in first gallbladder removal surgery featuring an autonomous AI-guided camera.
  • Surgery performed without a camera assistant; AI tracks surgeon’s tools and adjusts view in real time.
  • Marks a crucial step toward surgical automation, with potential to improve precision, workflow efficiency and reduce OR staffing needs.

Autonomous Camera Enables Solo Laparoscopic Surgery

At Clínica Las Condes in Santiago, Chile, a gallbladder removal surgery was carried out by a surgeon without a human camera operator. Instead, an autonomous, AI-powered camera tracked the surgeon’s tools and continuously adjusted its angle, maintaining optimal visualization throughout the procedure. Ricardo Funke, chief of surgery, reported that the camera “was following me wherever I moved my hands … the whole process was excellent.”

MARS Platform: Technology & Capabilities

The operation leveraged Levita’s Magnetic-Assisted Robotic Surgery (MARS) system combined with magnetic surgical instruments and software intelligence. The autonomous camera system, using a high-definition 4K camera, automatically tracked and followed instruments, reducing dependency on a camera assistant and offering a more stable visual field.

Implications for Surgical Workflow & Safety

This advance promises multiple benefits: enhancing precision in minimally invasive surgeries, reducing delays and mistakes caused by human camera movement, potentially lowering staffing needs in operating rooms, and possibly improving patient outcomes by maintaining consistent visual focus.

Towards Surgical Automation: What’s Next?

While this case is significant, it’s one of the first in real‐patient applications. Developers and regulators will need more data on safety, reliability, variability in anatomy, and adverse situations (e.g. unexpected bleeding or instrument occlusion). A broader adoption would require regulatory approvals, clinical trials, and integration into surgical training.

Releated Posts

Tsinghua’s Agent Hospital Pilots: World’s First AI Hospital or Closed Data Experiment?

Tsinghua University’s “world’s first AI Hospital” advanced public pilots February 28-March 2, 2026—deploying 42 AI agents across 300+…

ByByAnuja Singh Mar 4, 2026

Is Johnson & Johnson Preparing to Divest DePuy Synthes in a $20 Billion Strategic Pivot Toward Pharmaceuticals?

Will Johnson & Johnson’s Orthopedics Review Reshape the Global MedTech Landscape? Johnson & Johnson is reportedly exploring a…

ByByAnuja Singh Mar 1, 2026

Will Johnson & Johnson’s 2025 Earnings Reinforce Confidence in Its Pharma-Led Growth Engine?

Late January 2026 | Full-Year 2025 Earnings Preview | Diversified Pharma Outlook Johnson & Johnson (J&J) is set…

ByByAnuja Singh Jan 26, 2026

Is Canon Medical Systems Using AI to Transform Imaging, Diagnostics, and Patient Outcomes Globally?

Executive Summary Canon Medical Systems is advancing the integration of artificial intelligence, automated analytics, and cloud-enabled imaging solutions…

ByByAnuja Singh Jan 2, 2026
Scroll to Top